Otitis Media - Pipeline Review, H2 2016 - Global Markets Direct - Market Research

Otitis Media - Pipeline Review, H2 2016

Otitis Media - Pipeline Review, H2 2016 - Global Markets Direct - Market Research
Otitis Media - Pipeline Review, H2 2016
Published Jul 20, 2016
86 pages — Published Jul 20, 2016
Price US$ 2,000.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Global Markets Directs, Otitis Media - Pipeline Review, H2 2016, provides an overview of the Otitis Media pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Otitis Media, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Otitis Media and features dormant and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the global therapeutic landscape of Otitis Media
- The report reviews pipeline therapeutics for Otitis Media by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved Otitis Media therapeutics and enlists all their major and minor projects
- The report assesses Otitis Media therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news related to pipeline therapeutics for Otitis Media

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Otitis Media
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Otitis Media pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing

  
Source:
Document ID
GMDHC8236IDB
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents25
  List of Tables51
  List of Figures61
Introduction71
  Global Markets Direct Report Coverage71
Otitis Media Overview81
Therapeutics Development92
  Pipeline Products for Otitis Media Overview91
  Pipeline Products for Otitis Media Comparative Analysis101
Otitis Media Therapeutics under Development by Companies111
Otitis Media Therapeutics under Investigation by Universities/Institutes121
Otitis Media Pipeline Products Glance133
  Late Stage Products131
  Clinical Stage Products141
  Early Stage Products151
Otitis Media Products under Development by Companies161
Otitis Media Products under Investigation by Universities/Institutes171
Otitis Media Companies Involved in Therapeutics Development1810
  Cellceutix Corporation181
  ContraFect Corporation191
  GlaxoSmithKline Plc201
  Lee's Pharmaceutical Holdings Limited211
  Madam Therapeutics B.V.221
  Merck &Co., Inc.231
  MerLion Pharmaceuticals Pte Ltd241
  Oticpharma Ltd251
  Otonomy, Inc.261
  Yuhan Corporation271
Otitis Media Therapeutics Assessment2810
  Assessment by Monotherapy Products281
  Assessment by Combination Products291
  Assessment by Target302
  Assessment by Mechanism of Action322
  Assessment by Route of Administration342
  Assessment by Molecule Type362
Drug Profiles3838
  (dexamethasone acetate + piperacillin sodium + tazobactam sodium) Drug Profile381
  betahistine dihydrochloride Drug Profile391
  brilacidin tetrahydrochloride Drug Profile409
  CF-303 Drug Profile491
  CF-309 Drug Profile501
  ciprofloxacin hydrochloride Drug Profile514
  ciprofloxacin hydrochloride SR Drug Profile551
  finafloxacin Drug Profile563
  GSK-2189242A Drug Profile591
  pazufloxacin Drug Profile601
  PCL-1402 Drug Profile611
  Recombinant Peptide to Inhibit DNA for Otitis Media and Haemophilus Influenzae Infections Drug Profile621
  Small Molecules for Otitis Media Drug Profile631
  solithromycin Drug Profile6412
Otitis Media Dormant Projects761
Otitis Media Product Development Milestones778
  Featured News &Press Releases771
    May 20, 2016: Otonomy Announces Assignment of C Code and Pass-Through Payment Status for OTIPRIO771
    May 16, 2016: Otonomy Announces OTIPRIO Data Presentation and Symposium at Combined Otolaryngology Spring Meetings771
    Mar 18, 2016: Otonomy Announces Publication of OTIPRIO Phase 3 Clinical Trial Results in JAMA Otolaryngology781
    Mar 03, 2016: Otonomy Initiates Phase 2 Clinical Trial of OTIPRIO in Pediatric Patients With Acute Otitis Media With Tympanostomy Tubes781
    Mar 02, 2016: Otonomy Announces Commercial Availability of OTIPRIO791
    Dec 11, 2015: Otonomy Announces FDA Approval of OTIPRIO for the Treatment of Pediatric Patients Undergoing Tympanostomy Tube Placement Surgery791
    Nov 03, 2015: Otonomy Initiates Open-Label Clinical Trial for OTIPRIO in Pediatric Patients With History of Otitis Media Requiring Tympanostomy Tubes801
    Sep 24, 2015: Otonomy to Present Results for AuriPro Phase 3 Clinical Trials at 2015 AAO-HNSF Annual Meeting801
    May 07, 2015: Otonomy Completes Enrollment in Phase 2 Clinical Trial for AuriPro in Pediatric Patients With Acute Otitis Media With Tympanostomy Tubes811
    Apr 28, 2015: Otonomy Announces FDA Acceptance of AuriPro New Drug Application811
    Apr 27, 2015: Otonomy Presents AuriPro Phase 3 Results at American Society of Pediatric Otolaryngology Conference821
    Apr 21, 2015: Otonomy to Present AuriPro Phase 3 Results at American Society of Pediatric Otolaryngology Conference821
    Mar 26, 2015: Otonomy Initiates Phase 2 Clinical Trial for AuriPro in Label Expansion Indication831
    Feb 26, 2015: Otonomy Submits New Drug Application to the FDA for AuriPro831
    Jul 08, 2014: Otonomy Announces Positive Results from Two Phase 3 Trials of AuriPro in Pediatric Patients Undergoing Ear Tube Placement Surgery841
Appendix852
  Methodology851
  Coverage851
  Secondary Research851
  Primary Research851
  Expert Panel Validation851
  Contact Us851
  Disclaimer861

Table Of Contents

Global Markets Direct - Market Research—Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.

About the Author


Cite this Report

  
MLA:
Global Markets Direct - Market Research. "Otitis Media - Pipeline Review, H2 2016" Jul 20, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Otitis-Media-Pipeline-Review-H2-2016-2088-16210>
  
APA:
Global Markets Direct - Market Research. (2016). Otitis Media - Pipeline Review, H2 2016 Jul 20, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Otitis-Media-Pipeline-Review-H2-2016-2088-16210>
  
US$ 2,000.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.